NEWARK, N.Y., Sept. 22, 2022 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) has received a contract valued at approximately $7.5 million to supply its integrated system of A-320 amplifiers and A-320HVA radio vehicle mounts to a major international defense contractor for an ongoing
NEWARK, N.Y., July 28, 2022 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating income of $0.8 million and Adjusted EBITDA of $2.2 million on revenue of $32.1 million for the second quarter ended June 30, 2022. For the second quarter of 2021, the Company reported operating
NEWARK, N.Y., July 26, 2022 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) has been awarded a purchase order valued at approximately $4.6 million to supply its Vehicle Amplifier-Adaptors (“VAA”) to a global prime defense contractor. Ultralife’s VAA platform provides the soldier with an
NEWARK, N.Y., July 14, 2022 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its second quarter results for the period ended June 30, 2022, before the market opens on Thursday, July 28, 2022. Ultralife’s Management will also host an investor conference call and simultaneous
NEWARK, N.Y., April 28, 2022 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported an operating loss of $0.3 million on revenue of $30.4 million for the first quarter ended March 31, 2022. For the first quarter of 2021, the Company reported operating income of $1.0 million on revenue of
NEWARK, N.Y., April 14, 2022 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its first quarter results for the period ended March 31, 2022, before the market opens on Thursday, April 28, 2022. Ultralife’s Management will also host an investor conference call and simultaneous
NEWARK, N.Y., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported an operating loss of $1.2 million on revenue of $23.8 million for the fourth quarter ended December 31, 2021. For the fourth quarter of 2020, the Company reported operating income of $1.2 million on
NEWARK, N.Y., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its fourth quarter results for the period ended December 31, 2021 before the market opens on Thursday, February 3, 2022. Ultralife’s Management will also host an investor conference call and
Advances Ultralife’s Commercial Revenue Diversification Strategy NEWARK, N.Y., Dec. 14, 2021 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) has acquired all of the outstanding shares of Excell Battery Group (“Excell”) for $23.5 million in cash, subject to customary working capital and net
NEWARK, N.Y., Dec. 14, 2021 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) has received a firm-fixed price, indefinite-delivery/indefinite-quantity contract not to exceed $9.9 million from the U.S. Government’s Defense Logistics Agency (DLA) for its lithium manganese dioxide,
